BE-33-IM71_0.1uM Gene Set

Dataset NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles
Category transcriptomics
Type drug perturbation
Description Dose=0.1uM, 1-Naphthalenecarboxamide, 6-[(2-amino-4-pyrimidinyl)oxy]-N-[4-fluoro-3-(trifluoromethyl)phenyl]-, VEGFR-2 (FLK-1/KDR) Inhibitors targeting KDR (Novartis, 16071550)
External Link https://pubchem.ncbi.nlm.nih.gov/compound/16071550
Similar Terms
Downloads & Tools

Genes

8 genes differentially expressed following the BE-33-IM71_0.1uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.

increased expression

Symbol Name Standardized Value
ANXA2 annexin A2 0.589795
POLR2L polymerase (RNA) II (DNA directed) polypeptide L, 7.6kDa 0.589795
ARF6 ADP-ribosylation factor 6 0.423872
RPL18A ribosomal protein L18a 0.299554
RPS18 ribosomal protein S18 0.288676
IRAK1 interleukin-1 receptor-associated kinase 1 0.208401

decreased expression

Symbol Name Standardized Value
REEP6 receptor accessory protein 6 -0.396393
XAGE1A X antigen family member 1A -0.219913